Clinical Diagnostics


The race is on: Competition in cancer early detection intensifies

Introduction Oncology has driven adoption of precision medicine, which in turn has resulted in dramatic improvements for patient outcomes in some indications. Nevertheless, prognosis is often still poor for many

Precision medicine poised to disrupt fertility care paradigm

The fertility market is growing rapidly, as seen in many recent headlines highlighting deals in the space. Kindbody just achieved the largest fertility raise in history with a $62M Series

Multiplex Tissue Analysis + Digital Pathology in Clinical Research – A Summary of ASCO 2021 Findings

Background The range of technologies that enable multiplex tissue analysis (MTA) and digital pathology (DigPath) are rapidly growing and entering the clinical research space, providing new means of characterizing the

Navigating Companion Diagnostics (CDx) – Multiple Stakeholders, Many Goals

Background Companion diagnostic (CDx) tests are a foundational tool in precision medicine, helping ensure only the right patients receive the right therapies. The past several years have seen an explosion

DeciBio Analytics Launches 2021 DxBooks Databases

DeciBio Analytics has launched three 2021 DxBooks databases, covering U.S. labs’ testing behaviors in the areas of oncology biomarkers, infectious disease diagnostics, and SARS-CoV-2 testing. These databases, purchased in 2019

Update on the Adoption And Utilization of Emerging Precision Medicine Biomarkers and Technologies in Routine Clinical Care

At DeciBio Consulting, our mission is to provide market intelligence and insights to advance precision medicine.  To this end, we track this space closely, especially the field of precision oncology,

DeciBio’s Q&A with Brady Davis, SVP of Business Development for Canexia Health

  DeciBio had the pleasure of interviewing Canexia Health’s SVP of Business Development, Brady Davis. We interviewed Brady to understand how Canexia Health and Project ACTT (Access to Testing and

Collaborative, Decentralized Research Drives Liquid Biopsy Advances – AGBT 2020

  For AGBT 2020, we analyzed collaboration networks within liquid biopsy publications to understand the landscape. We analyzed ~2,600 liquid biopsy publications 1, indexing ~1,300 affiliations and ~15,000 authors in 60

Supplying the COVID Demand — How Dx Behemoths and Tele-Diagnostics Entrants Aim to Close the Gap

  As more COVID-19 diagnostics win FDA emergency use authorization, weekly commercial production capacity is expected to hit 6.5M+ tests; telehealth providers attempt to jump into the fray, but are